Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases.
Oltmanns F, Vieira Antão A, Irrgang P, Viherlehto V, Jörg L, Schmidt A, Wagner JT, Rückert M, Flohr AS, Geppert CI, Frey B, Bayer W, Gravekamp C, Tenbusch M, Gaipl U, Lapuente D. Oltmanns F, et al. Among authors: lapuente d. J Immunother Cancer. 2024 Mar 7;12(3):e008652. doi: 10.1136/jitc-2023-008652. J Immunother Cancer. 2024. PMID: 38458636 Free PMC article.
Immune suppression of vaccine-induced CD8+ T-cell responses by gamma retrovirus envelope is mediated by interleukin-10-producing CD4+ T cells.
Podschwadt P, Malyshkina A, Windmann S, Papadamakis A, Kerkmann L, Lapuente D, Tenbusch M, Lu M, Schindler M, Lang KS, Hansen W, Bayer W. Podschwadt P, et al. Among authors: lapuente d. Front Immunol. 2022 Dec 20;13:934399. doi: 10.3389/fimmu.2022.934399. eCollection 2022. Front Immunol. 2022. PMID: 36605206 Free PMC article.
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination.
Irrgang P, Gerling J, Kocher K, Lapuente D, Steininger P, Habenicht K, Wytopil M, Beileke S, Schäfer S, Zhong J, Ssebyatika G, Krey T, Falcone V, Schülein C, Peter AS, Nganou-Makamdop K, Hengel H, Held J, Bogdan C, Überla K, Schober K, Winkler TH, Tenbusch M. Irrgang P, et al. Among authors: lapuente d. Sci Immunol. 2023 Jan 27;8(79):eade2798. doi: 10.1126/sciimmunol.ade2798. Epub 2023 Jan 27. Sci Immunol. 2023. PMID: 36548397 Free PMC article.
Evaluation in a Cytokine Storm Model In Vivo of the Safety and Efficacy of Intravenous Administration of PRS CK STORM (Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells).
Lapuente JP, Gómez G, Marco-Brualla J, Fernández P, Desportes P, Sanz J, García-Gil M, Bermejo F, San Martín JV, Algaba A, De Gregorio JC, Lapuente D, De Gregorio A, Lapuente B, Gómez S, Andrés MLV, Anel A. Lapuente JP, et al. Among authors: lapuente d. Biomedicines. 2022 May 8;10(5):1094. doi: 10.3390/biomedicines10051094. Biomedicines. 2022. PMID: 35625831 Free PMC article.
Cytokine Profile and Anti-Inflammatory Activity of a Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells (PRS CK STORM).
Lapuente JP, Blázquez-Martínez A, Marco-Brualla J, Gómez G, Desportes P, Sanz J, Fernández P, García-Gil M, Bermejo F, San Martín JV, Algaba A, De Gregorio JC, Lapuente D, De Gregorio A, Lapuente B, Andrés MV, Anel A. Lapuente JP, et al. Among authors: lapuente d. Biomolecules. 2022 Mar 31;12(4):534. doi: 10.3390/biom12040534. Biomolecules. 2022. PMID: 35454123 Free PMC article.
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization.
Lapuente D, Fuchs J, Willar J, Vieira Antão A, Eberlein V, Uhlig N, Issmail L, Schmidt A, Oltmanns F, Peter AS, Mueller-Schmucker S, Irrgang P, Fraedrich K, Cara A, Hoffmann M, Pöhlmann S, Ensser A, Pertl C, Willert T, Thirion C, Grunwald T, Überla K, Tenbusch M. Lapuente D, et al. Nat Commun. 2021 Nov 26;12(1):6871. doi: 10.1038/s41467-021-27063-4. Nat Commun. 2021. PMID: 34836955 Free PMC article.
SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
Schmidt KG, Nganou-Makamdop K, Tenbusch M, El Kenz B, Maier C, Lapuente D, Überla K, Spriewald B, Bergmann S, Harrer EG, Harrer T. Schmidt KG, et al. Among authors: lapuente d. Front Immunol. 2021 Apr 28;12:627568. doi: 10.3389/fimmu.2021.627568. eCollection 2021. Front Immunol. 2021. PMID: 33995351 Free PMC article. Clinical Trial.
23 results